We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Imaging Agent Could Help Measure Effectiveness of Breast Cancer Therapy Earlier

News   Feb 12, 2019 | Original story from the Society of Nuclear Medicine and Molecular Imaging

 
Imaging Agent Could Help Measure Effectiveness of Breast Cancer Therapy Earlier

Representative coronal 18F-FFNP PET/CT images of MDA-MB-231 (red arrow), 231 PR-A (white arrows), and 231 PR-B (yellow arrow) tumor xenografts (19 d after implantation) from 12 mice imaged 1 h after injection with 10 MBq (270 μCi) of 18F-FFNP. Physiologic uptake from hepatobiliary clearance is also visualized. Credit: K Salem et al., University of Wisconsin School of Medicine and Public Health, Madison, WI

 
 
 

RELATED ARTICLES

Predicting Autism Risk May Begin With a Drop of Blood

News

A new research study will analyze blood for the presence of molecules that might predict autism risk years before symptoms appear.

READ MORE

Acid Reflux Drug Could Curb Premature Birth

News

An over-the-counter acid reflux drug called "lansoprazole" that is often taken by pregnant women could be a promising therapy to reduce preterm birth, according to a new study.

READ MORE

Molecular Roadmap Fuels Fight Against Endometrial Cancer

News

Dozens of molecular steps that bring about endometrial cancer have been analyzed, helping form a clearer "molecular roadmap" of events that fuel the disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE